1. Home
  2. COLD vs SYRE Comparison

COLD vs SYRE Comparison

Compare COLD & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americold Realty Trust Inc.

COLD

Americold Realty Trust Inc.

HOLD

Current Price

$12.20

Market Cap

3.4B

Sector

Real Estate

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$68.43

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLD
SYRE
Founded
1903
2013
Country
United States
United States
Employees
12690
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
4.0B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
COLD
SYRE
Price
$12.20
$68.43
Analyst Decision
Hold
Strong Buy
Analyst Count
15
12
Target Price
$15.17
$85.08
AVG Volume (30 Days)
3.7M
1.2M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
7.52%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,601,846,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$12.29
52 Week High
$20.30
$75.00

Technical Indicators

Market Signals
Indicator
COLD
SYRE
Relative Strength Index (RSI) 52.17 69.89
Support Level $11.98 $30.39
Resistance Level $12.24 $75.00
Average True Range (ATR) 0.36 4.60
MACD 0.08 1.13
Stochastic Oscillator 53.10 78.00

Price Performance

Historical Comparison
COLD
SYRE

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: